Katherine E. Olson

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions”.

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions

Frontiers in Immunology(2021)10.3389/fimmu.2021.741502

N/A

1.4DataRank · unranked

47 citations

Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, Vikas Kumar +8 more

The potential for treg-enhancing therapies in nervous system pathologies

Clinical & Experimental Immunology(2022)10.1093/cei/uxac084

N/A

1.3DataRank · unranked

52 citations

R. Lee Mosley, Howard E. Gendelman, Katherine E. Olson

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease

EBioMedicine(2021)10.1016/j.ebiom.2021.103380

N/A

1.2DataRank · unranked

58 citations

Krista L. Namminga, Yaman Lu, Aaron Schwab, Mackenzie J. Thurston, Mai Mohamed Abdelmoaty +7 more

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers

Translational Neurodegeneration(2023)10.1186/s40035-023-00361-1

N/A

0.759DataRank · unranked

33 citations

Mai Mohamed Abdelmoaty, Krista L. Namminga, Yaman Lu, Helen Obaro, Pamela M. Santamaria +3 more

Development of an extended half-life GM-CSF fusion protein for Parkinson's disease

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.06.024

N/A

0.550DataRank · unranked

38 citations

Katherine E. Olson, Yaman Lu, Mai Mohamed Abdelmoaty, Krista L. Namminga, Milica Marković +4 more

Humanized Mice for Infectious and Neurodegenerative disorders

Retrovirology(2021)10.1186/s12977-021-00557-1

N/A

0DataRank · unranked

40 citations

Santhi Gorantla, Larisa Y. Poluektova, Mahmudul Hasan, Emiko Waight, Chen Zhang +9 more

Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice

Neurotherapeutics(2020)10.1007/s13311-020-00877-8

N/A

0DataRank · unranked

38 citations

Krista L. Namminga, Aaron Schwab, Mackenzie J. Thurston, Yaman Lu, Ashley Woods +7 more

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease

NeuroImmune Pharmacology and Therapeutics(2022)10.1515/nipt-2022-0001

N/A

0DataRank · unranked

18 citations

Pravin Yeapuri, Krista L. Namminga, Yaman Lu, Maamoon Saleh, Katherine E. Olson +3 more

A multiyear follow-on study examining safety, immunity, and clinical outcomesfor sargramostim therapy in Parkinson’s disease

Research Square(2022)10.21203/rs.3.rs-1957469/v1

N/A

0DataRank · unranked

0 citations

Katherine E. Olson, Krista L. Namminga, Yaman Lu, Mai Mostafa, Helen Obaro +3 more

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Molecular Neurodegeneration(2023)10.1186/s13024-023-00692-7

N/A

0DataRank · unranked

76 citations

Jatin Machhi, Yaman Lu, Mai Mohamed Abdelmoaty, Rana Kadry, Milankumar Patel +8 more

CD4+ effector T cells accelerate Alzheimer’s disease in mice

Journal of Neuroinflammation(2021)10.1186/s12974-021-02308-7

N/A

0DataRank · unranked

154 citations

Pravin Yeapuri, Yaman Lu, Emma G. Foster, Rupesh V. Chikhale, Jonathan Herskovitz +15 more

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders

Molecular Neurodegeneration(2020)10.1186/s13024-020-00375-7

N/A

0DataRank · unranked

130 citations

Bhavesh D. Kevadiya, Ijaz Khan Muhammad, Jonathan Herskovitz, Katherine E. Olson, R. Lee Mosley +2 more